TrialJournal for immunotherapy of cancer2025

Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): conventional and distribution-based immune profiling of the tumor microenvironment and peripheral circulation.

Jingxuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.